Fatty acid induced metabolic memory involves alterations in renal histone H3K36me2 and H3K27me3

Molecular and Cellular Endocrinology

Volumn 422, Issue , 2016, Pages 233-242

  Kumar, Sandeep ^a   Pamulapati, Himani ^a   Tikoo, Kulbhushan ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Diabetic nephropathy; Epigenetics; Metabolic memory; Type 2 diabetes

Indexed keywords

FATTY ACID; GLUCOSE TRANSPORTER 4; HISTONE; HISTONE H3K27ME3; HISTONE H3K36ME2; INSULIN RECEPTOR; INSULIN RECEPTOR BETA; PROTEIN KINASE B; PROTEIN P21; PROTEIN P53; PYRUVATE DEHYDROGENASE KINASE 4; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, HUMAN; FOXO1 PROTEIN, RAT; NERVE PROTEIN; PALMITIC ACID DERIVATIVE; SLC2A4 PROTEIN, HUMAN; SLC2A4 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME PHOSPHORYLATION; EPIGENETICS; G6PC GENE; GENE; GENE EXPRESSION; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; HUMAN CELL; IGFBP1 GENE; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; INTRACELLULAR SIGNALING; KIDNEY DISEASE; MALE; METABOLIC MEMORY; METABOLIC PARAMETERS; MOLECULAR PATHOLOGY; NONHUMAN; P21 GENE; PDK4 GENE; PODOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; ANIMAL; CELL LINE; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; CELL LINE; FORKHEAD BOX PROTEIN O1; FORKHEAD TRANSCRIPTION FACTORS; GLUCOSE TRANSPORTER TYPE 4; HISTONES; HUMANS; INSULIN RESISTANCE; MALE; NERVE TISSUE PROTEINS; PALMITATES; PODOCYTES; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84956579296     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.12.019     Document Type: Article

References (55)

1. Abas L., Luschnig C. Maximum yields of microsomal-type membranes from small amounts of plant material without requiring ultracentrifugation. Anal. Biochem. 2010, 401:217-227.
2. Bannister A.J., Kouzarides T., Regulation of chromatin by histone modifications, Cell Res., 21, 381-395.
3. Barski A., Cuddapah S., Cui K., Roh T.-Y., Schones D.E., Wang Z., Wei G., Chepelev I., Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
4. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., Wei G., Chepelev I., Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
5. Battiprolu P.K., Hojayev B., Jiang N., Wang Z.V., Luo X., Iglewski M., Shelton J.M., Gerard R.D., Rothermel B.A., Gillette T.G., Lavandero S., Hill J.A. Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice. J. Clin. Invest. 2012, 122:1109-1118.
6. Blumenthal S.A. Stimulation of gluconeogenesis by palmitic acid in rat hepatocytes: evidence that this effect can be dissociated from the provision of reducing equivalents. Metabolism 1983, 32:971-976.
7. Ceriello A., Ihnat M.A., Thorpe J.E. Clinical review 2: the "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications?. J. Clin. Endocrinol. Metab. 2009, 94:410-415.
8. Edmunds J.W., Mahadevan L.C., Clayton A.L. Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation. EMBO J. 2007, 27:406-420.
9. Epidemiology of Diabetes Interventions and Complications (EDIC) Design, implementation, and preliminary results of a long-term follow-up of the diabetes control and complications trial cohort. Diabetes Care 1999, 22:99-111.
10. Gao D., Bailey C.J., Griffiths H.R. Metabolic memory effect of the saturated fatty acid, palmitate, in monocytes. Biochem. Biophys. Res. Commun. 2009, 388:278-282.
11. Gupta J., Tikoo K. Involvement of insulin-induced reversible chromatin remodeling in altering the expression of oxidative stress-responsive genes under hyperglycemia in 3T3-L1 preadipocytes. Gene 2012, 504:181-191.
12. Gupta J., Kumar S., Li J., Krishna Murthy Karuturi R., Tikoo K., Histone H3 lysine 4 mono methylation (H3K4me1) and H3 lysine 9 monomethylation (H3K9me1): distribution and their association in regulating gene expression under hyperglycemic/hyperinsulinemic conditions in 3T3 cells, Biochimie.
13. Ihnat M.A., Thorpe J.E., Ceriello A. Hypothesis: the 'metabolic memory', the new challenge of diabetes. Diabet. Med. 2007, 24:582-586.
14. Ihnat M.A., Thorpe J.E., Kamat C.D., Szabo C., Green D.E., Warnke L.A., Lacza Z., Cselenyak A., Ross K., Shakir S., Piconi L., Kaltreider R.C., Ceriello A. Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling. Diabetologia 2007, 50:1523-1531.
15. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
16. Karpe P.A., Tikoo K. Heat shock prevents insulin resistance-induced vascular complications by augmenting angiotensin-(1-7) signaling. Diabetes 2014, 63:1124-1139.
17. Kim M.S., Pak Y.K., Jang P.G., Namkoong C., Choi Y.S., Won J.C., Kim K.S., Kim S.W., Kim H.S., Park J.Y., Kim Y.B., Lee K.U. Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nat. Neurosci. 2006, 9:901-906.
18. Kim J.J., Li P., Huntley J., Chang J.P., Arden K.C., Olefsky J.M. FoxO1 haploinsufficiency protects against high-fat diet-induced insulin resistance with enhanced peroxisome proliferator-activated receptor gamma activation in adipose tissue. Diabetes 2009, 58:1275-1282.
19. Kimura H. Histone modifications for human epigenome analysis. J. Hum. Genet. 2013, 58:439-445.
20. Kowluru R.A., Chakrabarti S., Chen S. Re-institution of good metabolic control in diabetic rats and activation of caspase-3 and nuclear transcriptional factor (NF-kappaB) in the retina. Acta Diabetol. 2004, 41:194-199.
21. Kowluru R.A., Kowluru V., Xiong Y., Ho Y.S. Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Radic. Biol. Med. 2006, 41:1191-1196.
22. Kumar S., Tikoo K. Independent role of PP2A and mTORc1 in palmitate induced podocyte death. Biochimie 2015, 112:73-84.
23. Lennon R., Pons D., Sabin M.A., Wei C., Shield J.P., Coward R.J., Tavare J.M., Mathieson P.W., Saleem M.A., Welsh G.I. Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy. Nephrol. Dial. Transpl. 2009, 24:3288-3296.
24. Martin C., Zhang Y. The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell Biol. 2005, 6:838-849.
25. Matsuzaki H., Daitoku H., Hatta M., Tanaka K., Fukamizu A. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:11285-11290.
26. Miao F., Chen Z., Genuth S., Paterson A., Zhang L., Wu X., Li S.M., Cleary P., Riggs A., Harlan D.M., Lorenzi G., Kolterman O., Sun W., Lachin J.M., Natarajan R. Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes. Diabetes 2014, 63:1748-1762.
27. Miinea C.P., Sano H., Kane S., Sano E., Fukuda M., Peranen J., Lane W.S., Lienhard G.E. AS160, the Akt substrate regulating GLUT4 translocation, has a functional Rab GTPase-activating protein domain. Biochem. J. 2005, 391:87-93.
28. Nakae J., Kitamura T., Silver D.L., Accili D. The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J. Clin. Invest. 2001, 108:1359-1367.
29. Nakamura S., Takamura T., Matsuzawa-Nagata N., Takayama H., Misu H., Noda H., Nabemoto S., Kurita S., Ota T., Ando H., Miyamoto K., Kaneko S. Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. J. Biol. Chem. 2009, 284:14809-14818.
30. Orchard T.J., Chang Y.F., Ferrell R.E., Petro N., Ellis D.E. Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh epidemiology of diabetes complication Study. Kidney Int. 2002, 62:963-970.
31. Pan D., Mao C., Zou T., Yao A.Y., Cooper M.P., Boyartchuk V., Wang Y.X. The histone demethylase Jhdm1a regulates hepatic gluconeogenesis. PLoS Genet. 2012, 8:e1002761.
32. Pirola L., Balcerczyk A., Tothill R.W., Haviv I., Kaspi A., Lunke S., Ziemann M., Karagiannis T., Tonna S., Kowalczyk A., Beresford-Smith B., Macintyre G., Kelong M., Hongyu Z., Zhu J., El-Osta A. Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Res. 2011, 21:1601-1615.
33. Qureshi I.A., Mehler M.F. Chromatin-modifying agents for epigenetic reprogramming and endogenous neural stem cell-mediated repair in stroke. Transl. Stroke Res. 2011, 2:7-16.
34. Rao B., Shibata Y., Strahl B.D., Lieb J.D. Dimethylation of histone H3 at lysine 36 demarcates regulatory and nonregulatory chromatin genome-wide. Mol. Cell Biol. 2005, 25:9447-9459.
35. Reddy M.A., Sumanth P., Lanting L., Yuan H., Wang M., Mar D., Alpers C.E., Bomsztyk K., Natarajan R. Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice. Kidney Int. 2014, 85:362-373.
36. Ropelle E.R., Pauli J.R., Prada P., Cintra D.E., Rocha G.Z., Moraes J.C., Frederico M.J., da Luz G., Pinho R.A., Carvalheira J.B., Velloso L.A., Saad M.A., De Souza C.T. Inhibition of hypothalamic Foxo1 expression reduced food intake in diet-induced obesity rats. J. Physiol. 2009, 587:2341-2351.
37. Sabin M.A., De Hora M., Holly J.M., Hunt L.P., Ford A.L., Williams S.R., Baker J.S., Retallick C.J., Crowne E.C., Shield J.P. Fasting nonesterified fatty acid profiles in childhood and their relationship with adiposity, insulin sensitivity, and lipid levels. Pediatrics 2007, 120:e1426-1433.
38. Salih D.A., Brunet A. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr. Opin. Cell Biol. 2008, 20:126-136.
39. Schisano B., Tripathi G., McGee K., McTernan P.G., Ceriello A. Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells. Diabetologia 2011, 54:1219-1226.
40. Sidaway P. Diabetes: epigenetic changes lead to impaired wound healing in patients with T2DM. Nat. Rev. Endocrinol. 2015, 11:65.
41. Sieber J., Jehle A.W. Free fatty acids and their metabolism affect function and survival of podocytes. Front. Endocrinol. (Lausanne) 2014, 5:186.
42. Svensson M., Eriksson J.W. Insulin resistance in diabetic nephropathy-cause or consequence?. Diabetes Metab. Res. Rev. 2006, 22:401-410.
43. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus The diabetes control and complications trial research group. N. Engl. J. Med. 1993, 329:977-986.
44. Thomasova D., Anders H.J. Cell cycle control in the kidney. Nephrol. Dial. Transpl. 2014, 30(10):1622-1630.
45. Tikoo K., Patel G., Kumar S., Karpe P.A., Sanghavi M., Malek V., Srinivasan K. Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications. Biochem. Pharmacol. 2014 Feb 1, 93(3):343-351.
46. Tikoo K., Lodea S., Karpe P.A., Kumar S. Calorie restriction mimicking effects of roflumilast prevents diabetic nephropathy. Biochem. Biophys. Res. Commun. 2014, 450:1581-1586.
47. Tinkum K.L., White L.S., Marpegan L., Herzog E., Piwnica-Worms D., Piwnica-Worms H. Forkhead box O1 (FOXO1) protein, but not p53, contributes to robust induction of p21 expression in fasted mice. J. Biol. Chem. 2013, 288:27999-28008.
48. Tsintzas K., Chokkalingam K., Jewell K., Norton L., Macdonald I.A., Constantin-Teodosiu D. Elevated free fatty acids attenuate the insulin-induced suppression of PDK4 gene expression in human skeletal muscle: potential role of intramuscular long-chain acyl-coenzyme A. J. Clin. Endocrinol. Metab. 2007, 92:3967-3972.
49. Villeneuve L.M., Reddy M.A., Lanting L.L., Wang M., Meng L., Natarajan R. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9047-9052.
50. Villeneuve L.M., Reddy M.A., Natarajan R. Epigenetics: deciphering its role in diabetes and its chronic complications. Clin. Exp. Pharmacol. Physiol. 2011, 38:451-459.
51. Wagner K.W., Alam H., Dhar S.S., Giri U., Li N., Wei Y., Giri D., Cascone T., Kim J.H., Ye Y., Multani A.S., Chan C.H., Erez B., Saigal B., Chung J., Lin H.K., Wu X., Hung M.C., Heymach J.V., Lee M.G. KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling. J. Clin. Invest. 2013, 123:5231-5246.
52. Wu H., Min J., Lunin V.V., Antoshenko T., Dombrovski L., Zeng H., Allali-Hassani A., Campagna-Slater V.r., Vedadi M., Arrowsmith C.H., Structural biology of human H3K9 methyltransferases, PloS One, 5, e8570.
53. Zhong Q., Kowluru R.A. Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon. J. Cell Biochem. 2010, 110:1306-1313.
54. Zhong Q., Kowluru R.A. Epigenetic changes in mitochondrial superoxide dismutase in the retina and the development of diabetic retinopathy. Diabetes 2011, 60:1304-1313.
55. Zhong Q., Kowluru R.A. Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation. Invest Ophthalmol. Vis. Sci. 2013, 54:244-250.